5-hydroxydecanoate and tei 3356

5-hydroxydecanoate has been researched along with tei 3356 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Olbrich, A; Thiemermann, C; Zacharowski, K	1

Other Studies

1 other study(ies) available for 5-hydroxydecanoate and tei 3356

Article	Year
Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)-channels. European journal of pharmacology, 1999, Feb-12, Volume: 367, Issue:1 Topics: Adenosine Triphosphate; Alkaloids; Animals; Anti-Arrhythmia Agents; Benzophenanthridines; Decanoic Acids; Enzyme Inhibitors; Epoprostenol; Hemodynamics; Hydroxy Acids; Male; Myocardial Infarction; Myocardial Reperfusion; Phenanthridines; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Staurosporine	1999

Article

Year

Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)-channels.

European journal of pharmacology, 1999, Feb-12, Volume: 367, Issue:1

Topics: Adenosine Triphosphate; Alkaloids; Animals; Anti-Arrhythmia Agents; Benzophenanthridines; Decanoic Acids; Enzyme Inhibitors; Epoprostenol; Hemodynamics; Hydroxy Acids; Male; Myocardial Infarction; Myocardial Reperfusion; Phenanthridines; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Rats; Rats, Wistar; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; Staurosporine

1999